Skip to content

To investigate whether probiotics can delay the development of paraneoplastic thrombocythemia in patients with ovarian cancer through their effects on intestinal flora

To investigate whether probiotics can delay the development of paraneoplastic thrombocythemia in patients with ovarian cancer through their effects on intestinal flora

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067850
Enrollment
Unknown
Registered
2023-01-29
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Interventions

Group1:Bifidobacterium longum

Sponsors

The Second People's Hospital of Jingdezhen
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Ovarian cancer patients with PLT count greater than 300 x 10^9/L; 2. Epithelial ovarian cancer (serous adenocarcinoma, mucous adenocarcinoma, endometrioid adenocarcinoma, etc.) was confirmed by puncture pathology or highly suspected ovarian cancer was confirmed by postoperative pathology; 3. The patient was generally in good condition, aged 18-75 years, and did not have serious heart, lung, kidney, liver dysfunction or metabolic diseases.; 4. 6 courses of TC chemotherapy were received after surgery; Fresh, meso-posterior, and internal fecal samples of 10 g were collected and quickly stored at -80 degree C. Fecal DNA extraction and 16S rRNA gene sequencing were performed for intestinal flora detection; 5. No antibiotics or other drugs were used in the first 3 months after the completion of treatment.

Exclusion criteria

Exclusion criteria: 1. Have hemophilia or abnormal diseases related to the blood system; 2. Other immune diseases that cause PLT abnormality; 3. With other cancers; 4. Other chronic diseases.

Design outcomes

Primary

MeasureTime frame
platelets;Fecal flora;

Secondary

MeasureTime frame
CA125;HE4;Coagulation function;

Countries

China

Contacts

Public ContactXiaohui Wang

The Second People's Hospital of Jingdezhen

1007219161@qq.com+86 136 4798 2966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026